CHRIS HOY ANNOUNCES HIS CANCER IS TERMINAL
The six-time Olympic champion, who was initially diagnosed with prostate cancer, shared that the disease has spread to other parts of his body and is incurable. He has been given a prognosis of two to four years to live. Hoy has been undergoing treatment to manage the disease, but despite Continue Reading
HOW THE MANIFESTOS STACK AGAINST NHS BILL
The parties’ manifestos, including the contract Reform UK, and Labour, have been released, and the campaigns are entering the final straight. However, many of the numbers floating around are close to useless, particularly regarding the next government’s spending plans on public services. The NHS is the largest public service often Continue Reading
NOVO NORDISK SUSPENDED IN UK OVER DIET DRUG STUDY
Novo Nordisk, a Danish pharmaceutical company, has been suspended from the UK’s pharma trade body for not being transparent in its promotion of its weight-loss predecessor, liraglutide, to doctors. The company is currently involved in a study that found that its weight-loss drug semaglutide reduces the risk of heart attacks, Continue Reading
REVIEW ON PAYING PERSONAL INDEPENDENCE PAYMENT
UK Minister Mel Stride has announced plans to overhaul the way disability benefits work, aiming to put pressure on Labour before a general election. The plans include changes to eligibility criteria and assessments, aiming to change personal independence payments (Pip), the main disability benefit for adults. Stride argued that the Continue Reading
The Tobacco and Vapes Bill, championed by Prime Minister Rishi Sunak, has passed by 383 votes to 67 in the House of Commons. Health Secretary Victoria Atkins defended the plans, stating that there is no liberty in addiction. The bill passed by 383 votes to 67, creating a “smoke-free generation” Continue Reading
PAINKILLER & PAIN MAKER – OXYCONTIN’S LEGACY
Purdue Pharma, a privately held American pharmaceutical company, was involved in the opioid crisis due to its aggressive marketing tactics for OxyContin, a pain medication. The company faced lawsuits and paid large fines, eventually filing for bankruptcy in 2019. In 2020, Purdue reached a potential $8.3 billion settlement with the Continue Reading
